{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:07:26Z","timestamp":1791846446027,"version":"4.3.4"},"reference-count":173,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzen Municipality","doi-asserted-by":"publisher","award":["SZSM202211038"],"award-info":[{"award-number":["SZSM202211038"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shenzhen Key Laboratory of Orthopaedic Diseases and Biomaterials Research","award":["ZDSYS20220606100602005"],"award-info":[{"award-number":["ZDSYS20220606100602005"]}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022A1515220038"],"award-info":[{"award-number":["2022A1515220038"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shenzhen High-Level Hospital Construction Fund, the Shenzhen Key Medical Discipline Construction Fund","award":["SZXK023"],"award-info":[{"award-number":["SZXK023"]}]},{"name":"Shenzhen Sustainable Development Project","award":["KCXFZ20201221173411031"],"award-info":[{"award-number":["KCXFZ20201221173411031"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00210-025-04497-x","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T04:34:26Z","timestamp":1754973266000},"page":"1381-1410","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Targeting cuproptosis opens a new chapter of nanomedicine: a scientometric and graphical analysis"],"prefix":"10.1007","volume":"399","author":[{"given":"Siyang","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchen","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"key":"4497_CR1","doi-asserted-by":"crossref","first-page":"1416382","DOI":"10.3389\/fphar.2024.1416382","volume":"15","author":"KP Adzavon","year":"2024","unstructured":"Adzavon KP, Zhao W, He X, Sheng W (2024) Ferroptosis resistance in cancer cells: nanoparticles for combination therapy as a solution. Front Pharmacol 15:1416382","journal-title":"Front Pharmacol"},{"issue":"1","key":"4497_CR2","volume":"1","author":"R Ahmadi","year":"2024","unstructured":"Ahmadi R (2024) Emerging innovations in AI-driven medical imaging: elevating diagnostic precision and therapeutic decision-making. Journal of AI-Powered Medical Innovations (International online ISSN: 3078-1930) 1(1):1\u201328","journal-title":"Journal of AI-Powered Medical Innovations (International online ISSN: 3078-1930)"},{"key":"4497_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28052303","author":"R Aishajiang","year":"2023","unstructured":"Aishajiang R, Liu Z, Wang T, Zhou L, Yu D (2023) Recent advances in cancer therapeutic copper-based nanomaterials for antitumor therapy. Molecules. https:\/\/doi.org\/10.3390\/molecules28052303","journal-title":"Molecules"},{"issue":"1","key":"4497_CR4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.60087\/vol2iisue1.p21","volume":"2","author":"S Akter","year":"2024","unstructured":"Akter S (2024) AI-driven precision medicine: transforming personalized cancer treatment. Journal of AI-Powered Medical Innovations (International Online ISSN 3078-1930) 2(1):10\u201321","journal-title":"Journal of AI-Powered Medical Innovations (International Online ISSN 3078-1930)"},{"key":"4497_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13225810","author":"A Alkaraki","year":"2021","unstructured":"Alkaraki A, Mcarthur GA, Sheppard KE, Smith LK (2021) Metabolic plasticity in melanoma progression and response to oncogene targeted therapies. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13225810","journal-title":"Cancers (Basel)"},{"key":"4497_CR6","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.4c00838","author":"MB Almeida","year":"2024","unstructured":"Almeida MB, Galdiano CMR, Silva Benvenuto F, Carrilho E, Brazaca LC (2024) Strategies employed to design biocompatible metal nanoparticles for medical science and biotechnology applications. ACS Appl Mater Interfaces. https:\/\/doi.org\/10.1021\/acsami.4c00838","journal-title":"ACS Appl Mater Interfaces"},{"key":"4497_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14040883","author":"SZ Alshawwa","year":"2022","unstructured":"Alshawwa SZ, Kassem AA, Farid RM, Mostafa SK, Labib GS (2022) Nanocarrier drug delivery systems: characterization, limitations, future perspectives and implementation of artificial intelligence. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics14040883","journal-title":"Pharmaceutics"},{"key":"4497_CR8","doi-asserted-by":"crossref","unstructured":"Argentiero, A., Andriano, A., Caradonna, I. C., De Martino, G. & Desantis, V (2024) Decoding the intricate landscape of pancreatic cancer: insights into tumor biology, microenvironment, and therapeutic interventions. Cancers (Basel) 16","DOI":"10.3390\/cancers16132438"},{"key":"4497_CR9","doi-asserted-by":"crossref","unstructured":"Arya, N., Mathur, H., Chatterjee, N. & Jadon, R (2024) Exploring the role of artificial intelligence and machine learning in pharmaceutical formulation design. Int J Newgen Res Pharm Healthc 30\u201341.","DOI":"10.61554\/ijnrph.v2i1.2024.67"},{"key":"4497_CR10","doi-asserted-by":"crossref","unstructured":"Bai, J., Zhang, X., Zhao, Z., Sun, S., Cheng, W., Yu, H., Chang, X. & Wang, B (2024) CuO nanozymes catalyze cysteine and glutathione depletion induced ferroptosis and cuproptosis for synergistic tumor therapy. Small  2400326","DOI":"10.1002\/smll.202400326"},{"key":"4497_CR11","doi-asserted-by":"crossref","unstructured":"Bawa, R (2011) Regulating nanomedicine - can the FDA handle it?. Curr Drug Deliv 8: 227\u201334","DOI":"10.2174\/156720111795256156"},{"key":"4497_CR12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jtemb.2016.02.006","volume":"35","author":"M Bost","year":"2016","unstructured":"Bost M, Houdart S, Oberli M, Kalonji E, Huneau JF, Margaritis I (2016) Dietary copper and human health: current evidence and unresolved issues. J Trace Elem Med Biol 35:107\u2013115","journal-title":"J Trace Elem Med Biol"},{"key":"4497_CR13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jtos.2017.10.002","volume":"16","author":"C Boudry","year":"2018","unstructured":"Boudry C, Baudouin C, Mouriaux FD (2018) International publication trends in dry eye disease research: a bibliometric analysis. Ocul Surf 16:173\u2013179","journal-title":"Ocul Surf"},{"key":"4497_CR14","volume":"9","author":"Y Cao","year":"2014","unstructured":"Cao Y, Rathmell JC, Macintyre AN (2014) Metabolic reprogramming towards aerobic glycolysis correlates with greater proliferative ability and resistance to metabolic inhibition in CD8 versus CD4 T cells. PLoS One 9:e104104","journal-title":"PLoS One"},{"key":"4497_CR15","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.2147\/JMDH.S477219","volume":"17","author":"S Cao","year":"2024","unstructured":"Cao S, Wei Y, Yue Y, Wang D, Xiong A, Zeng H (2024) A scientometric worldview of artificial intelligence in musculoskeletal diseases since the 21st century. J Multidiscip Healthc 17:3193\u20133211","journal-title":"J Multidiscip Healthc"},{"key":"4497_CR16","doi-asserted-by":"crossref","first-page":"155949","DOI":"10.1016\/j.prp.2025.155949","volume":"269","author":"S Cao","year":"2025","unstructured":"Cao S, Pang Y, Wei Y, Wang D, Xiong A, Yan J, Zeng H (2025a) Bibliometric and graphical analysis of ferroptosis and aging research: trends, gaps, and future directions. Pathology - Research and Practice 269:155949","journal-title":"Pathology - Research and Practice"},{"key":"4497_CR17","doi-asserted-by":"crossref","first-page":"1553915","DOI":"10.3389\/fmed.2025.1553915","volume":"12","author":"S Cao","year":"2025","unstructured":"Cao S, Pang Y, Wei Y, Wang D, Xiong A, Yang J, Zeng H (2025b) Unveiling the dynamic trends of plant-derived exosome nanovesicles-based theranostics: through bibliometric and visualized analysis. Front Med 12:1553915","journal-title":"Front Med"},{"key":"4497_CR18","doi-asserted-by":"crossref","first-page":"142798","DOI":"10.1016\/j.ijbiomac.2025.142798","volume":"309","author":"S Cao","year":"2025","unstructured":"Cao S, Pang Y, Wei Y, Wang D, Xiong A, Yang J, Zeng H (2025c) Nanozymes in biomedicine: unraveling trends, research foci, and future trajectories via bibliometric insights (from 2007 to 2024). Int J Biol Macromol 309:142798","journal-title":"Int J Biol Macromol"},{"key":"4497_CR19","doi-asserted-by":"crossref","first-page":"528","DOI":"10.7150\/ijms.104697","volume":"22","author":"S Cao","year":"2025","unstructured":"Cao S, Wei Y, Yue Y, Wang D, Xiong A, Yang J, Zeng H (2025d) Research trends and dynamics in single-cell RNA sequencing for musculoskeletal diseases: a scientometric and visualization study. Int J Med Sci 22:528\u2013550","journal-title":"Int J Med Sci"},{"key":"4497_CR20","doi-asserted-by":"crossref","first-page":"508","DOI":"10.7150\/ijms.104222","volume":"22","author":"S Cao","year":"2025","unstructured":"Cao S, Wei Y, Yue Y, Wang D, Xiong A, Zeng H (2025e) Deciphering epigenetic and post-translational modifications in ferroptosis: a scientometric and visualization study. Int J Med Sci 22:508\u2013527","journal-title":"Int J Med Sci"},{"key":"4497_CR21","doi-asserted-by":"crossref","first-page":"34045","DOI":"10.1039\/D3RA06434D","volume":"13","author":"R Cazzoli","year":"2023","unstructured":"Cazzoli R, Zamborlin A, Ermini ML, Salerno A, Curcio M, Nicoletta FP, Iemma F, Vittorio O, Voliani V, Cirillo G (2023) Evolving approaches in glioma treatment: harnessing the potential of copper metabolism modulation. RSC Adv 13:34045\u201334056","journal-title":"RSC Adv"},{"key":"4497_CR22","doi-asserted-by":"crossref","first-page":"e2308565","DOI":"10.1002\/smll.202308565","volume":"20","author":"J Chang","year":"2024","unstructured":"Chang J, Yin W, Zhi H, Chen S, Sun J, Zhao Y, Huang L, Xue L, Zhang X, Zhang T, Dong H, Li Y (2024) Copper deposition in polydopamine nanostructure to promote cuproptosis by catalytically inhibiting copper exporters of tumor cells for cancer immunotherapy. Small 20:e2308565","journal-title":"Small"},{"key":"4497_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/metabo10070289","author":"X Chen","year":"2020","unstructured":"Chen X, Chen S, Yu D (2020) Metabolic reprogramming of chemoresistant cancer cells and the potential significance of metabolic regulation in the reversal of cancer chemoresistance. Metabolites. https:\/\/doi.org\/10.3390\/metabo10070289","journal-title":"Metabolites"},{"key":"4497_CR24","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/s41392-022-01229-y","volume":"7","author":"L Chen","year":"2022","unstructured":"Chen L, Min J, Wang F (2022a) Copper homeostasis and cuproptosis in health and disease. Signal Transduct Target Ther 7:378","journal-title":"Signal Transduct Target Ther"},{"key":"4497_CR25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jconrel.2021.11.041","volume":"341","author":"M Chen","year":"2022","unstructured":"Chen M, Huang Z, Xia M, Ding Y, Shan T, Guan Z, Dai X, Xu X, Huang Y, Huang M, Zhao C (2022b) Glutathione-responsive copper-disulfiram nanoparticles for enhanced tumor chemotherapy. J Control Release 341:351\u2013363","journal-title":"J Control Release"},{"key":"4497_CR26","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1039\/D1DT03749H","volume":"51","author":"YT Chen","year":"2022","unstructured":"Chen YT, Zhang SN, Wang ZF, Wei QM, Zhang SH (2022c) Discovery of thirteen cobalt(II) and copper(II) salicylaldehyde Schiff base complexes that induce apoptosis and autophagy in human lung adenocarcinoma A549\/DDP cells and that can overcome cisplatin resistance in vitro and in vivo. Dalton Trans 51:4068\u20134078","journal-title":"Dalton Trans"},{"key":"4497_CR27","doi-asserted-by":"crossref","first-page":"2303694","DOI":"10.1002\/advs.202303694","volume":"10","author":"W Chen","year":"2023","unstructured":"Chen W, Xie W, Gao Z, Lin C, Tan M, Zhang Y, Hou Z (2023a) Mildhphotothermal effect induced high efficiency ferroptosis-boosted-cuproptosis based on Cu2O@ Mn3Cu3O8 nanozyme. Adv Sci 10:2303694","journal-title":"Adv Sci"},{"key":"4497_CR28","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41419-023-05639-w","volume":"14","author":"X Chen","year":"2023","unstructured":"Chen X, Cai Q, Liang R, Zhang D, Liu X, Zhang M, Xiong Y, Xu M, Liu Q, Li P, Yu P, Shi A (2023b) Copper homeostasis and copper-induced cell death in the pathogenesis of cardiovascular disease and therapeutic strategies. Cell Death Dis 14:105","journal-title":"Cell Death Dis"},{"key":"4497_CR29","doi-asserted-by":"crossref","first-page":"eadk3201","DOI":"10.1126\/sciadv.adk3201","volume":"10","author":"K Chen","year":"2024","unstructured":"Chen K, Zhou A, Zhou X, He J, Xu Y, Ning X (2024) Cellular trojan horse initiates bimetallic Fe-Cu MOF-mediated synergistic cuproptosis and ferroptosis against malignancies. Sci Adv 10:eadk3201","journal-title":"Sci Adv"},{"key":"4497_CR30","doi-asserted-by":"crossref","unstructured":"Chen, L., Wu, Q., Lin, C., Song, Z., Su, Y., Ge, C., Wang, X., Luo, H., Wang, R., Wang, Y., Min, J. & Wang, F (2025) Integrative analysis of copper dysregulation and cuproptosis in postnatal hematopoiesis. Sci Bull (Beijing).","DOI":"10.1016\/j.scib.2025.05.019"},{"key":"4497_CR31","doi-asserted-by":"crossref","first-page":"101894","DOI":"10.1016\/j.mtbio.2025.101894","volume":"32","author":"H Cheng","year":"2025","unstructured":"Cheng H, Zhao L, Cai J (2025) Cuproptosis-driven nanostrategies: synergistic nanoplatforms for tumor microenvironment reprogramming and enhanced anticancer efficacy. Mater Today Bio 32:101894","journal-title":"Mater Today Bio"},{"key":"4497_CR32","doi-asserted-by":"crossref","first-page":"103552","DOI":"10.1016\/j.redox.2025.103552","volume":"81","author":"N Chrzan","year":"2025","unstructured":"Chrzan N, Hartman ML (2025) Copper in melanoma: at the crossroad of protumorigenic and anticancer roles. Redox Biol 81:103552","journal-title":"Redox Biol"},{"key":"4497_CR33","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1016\/j.xphs.2024.09.005","volume":"113","author":"JD Clogston","year":"2024","unstructured":"Clogston JD, Foss W, Harris D, Oberoi H, Pan J, Pu E, GUZM\u00e1N EAT, Walter K, Brown S, Soo PL (2024) Current state of nanomedicine drug products: an industry perspective. J Pharm Sci 113:3395\u20133405","journal-title":"J Pharm Sci"},{"key":"4497_CR34","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/j.molcel.2022.05.001","volume":"82","author":"PA Cobine","year":"2022","unstructured":"Cobine PA, Brady DC (2022) Cuproptosis: cellular and molecular mechanisms underlying copper-induced cell death. Mol Cell 82:1786\u20131787","journal-title":"Mol Cell"},{"key":"4497_CR35","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41587-020-0707-9","volume":"39","author":"L Cui","year":"2021","unstructured":"Cui L, Gouw AM, Lagory EL, Guo S, Attarwala N, Tang Y, Qi J, Chen YS, Gao Z, Casey KM, Bazhin AA, Chen M, Hu L, Xie J, Fang M, Zhang C, Zhu Q, Wang Z, Giaccia AJ, Gambhir SS, Zhu W, Felsher DW, Pegram MD, Goun EA, Le A, Rao J (2021) Mitochondrial copper depletion suppresses triple-negative breast cancer in mice. Nat Biotechnol 39:357\u2013367","journal-title":"Nat Biotechnol"},{"key":"4497_CR36","doi-asserted-by":"crossref","first-page":"111634","DOI":"10.1016\/j.jinorgbio.2021.111634","volume":"226","author":"DA DA Silva","year":"2022","unstructured":"DA Silva DA, DE Luca A, Squitti R, Rongioletti M, Rossi L, Machado CML, Cerchiaro G (2022) Copper in tumors and the use of copper-based compounds in cancer treatment. J Inorg Biochem 226:111634","journal-title":"J Inorg Biochem"},{"key":"4497_CR37","doi-asserted-by":"crossref","first-page":"727","DOI":"10.5588\/ijtld.16.0940","volume":"21","author":"M Dara","year":"2017","unstructured":"Dara M, Sulis G, Centis R, D\u2019Ambrosio L, de Vries G, Douglas P, Garcia D, Jansen N, Zuroweste E, Migliori GB (2017) Cross-border collaboration for improved tuberculosis prevention and care: policies, tools and experiences. Int J Tuberc Lung Dis 21:727\u2013736","journal-title":"Int J Tuberc Lung Dis"},{"key":"4497_CR38","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/17435390.2018.1530390","volume":"13","author":"WH de Jong","year":"2019","unstructured":"de Jong WH, de Rijk E, Bonetto A, Wohlleben W, Stone V, Brunelli A, Badetti E, Marcomini A, Gosens I, Cassee FR (2019) Toxicity of copper oxide and basic copper carbonate nanoparticles after short-term oral exposure in rats. Nanotoxicology 13:50\u201372","journal-title":"Nanotoxicology"},{"key":"4497_CR39","first-page":"444","volume":"16","author":"J Di","year":"2021","unstructured":"Di J, Gao X, Du Y, Zhang H, Gao J, Zheng A (2021) Size, shape, charge and \u201cstealthy\u201d surface: Carrier properties affect the drug circulation time in vivo. Asian J Pharm Sci 16:444\u2013458","journal-title":"Asian J Pharm Sci"},{"key":"4497_CR40","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s10660-020-09410-7","volume":"22","author":"X Ding","year":"2022","unstructured":"Ding X, Yang Z (2022) Knowledge mapping of platform research: a visual analysis using VOSviewer and citespace. Electron Commer Res 22:787\u2013809","journal-title":"Electron Commer Res"},{"key":"4497_CR41","doi-asserted-by":"crossref","first-page":"102509","DOI":"10.1016\/j.cis.2021.102509","volume":"296","author":"B Dutta","year":"2021","unstructured":"Dutta B, Barick KC, Hassan PA (2021) Recent advances in active targeting of nanomaterials for anticancer drug delivery. Adv Colloid Interface Sci 296:102509","journal-title":"Adv Colloid Interface Sci"},{"key":"4497_CR42","doi-asserted-by":"crossref","first-page":"1290592","DOI":"10.3389\/fphar.2024.1290592","volume":"15","author":"Q Feng","year":"2024","unstructured":"Feng Q, Huo C, Wang M, Huang H, Zheng X, Xie M (2024a) Research progress on cuproptosis in cancer. Front Pharmacol 15:1290592","journal-title":"Front Pharmacol"},{"key":"4497_CR43","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s12964-024-01625-7","volume":"22","author":"Y Feng","year":"2024","unstructured":"Feng Y, Yang Z, Wang J, Zhao H (2024b) Cuproptosis: unveiling a new frontier in cancer biology and therapeutics. Cell Commun Signal 22:249","journal-title":"Cell Commun Signal"},{"key":"4497_CR44","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/s41586-019-1770-6","volume":"575","author":"M Fritsch","year":"2019","unstructured":"Fritsch M, G\u00fcNTHER SD, Schwarzer R, Albert M-C, Schorn F, Werthenbach JP, Schiffmann LM, Stair N, Stocks H, Seeger JM, Lamkanfi M, KR\u00f6NKE M, Pasparakis M, Kashkar H (2019) Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis. Nature 575:683\u2013687","journal-title":"Nature"},{"key":"4497_CR45","doi-asserted-by":"crossref","first-page":"113910","DOI":"10.1016\/j.addr.2021.113910","volume":"179","author":"P Fu","year":"2021","unstructured":"Fu P, Zhang J, Li H, Mak M, Xu W, Tao Z (2021a) Extracellular vesicles as delivery systems at nano-\/micro-scale. Adv Drug Deliv Rev 179:113910","journal-title":"Adv Drug Deliv Rev"},{"key":"4497_CR46","doi-asserted-by":"crossref","first-page":"20200149","DOI":"10.1002\/VIW.20200149","volume":"2","author":"Q Fu","year":"2021","unstructured":"Fu Q, Zhang X, Song J, Yang H (2021b) Plasmonic gold nanoagents for cancer imaging and therapy. View 2:20200149","journal-title":"View"},{"key":"4497_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41589-025-01841-3","author":"W Fu","year":"2025","unstructured":"Fu W, Wang J, Li T, Qiao Y, Zhang Z, Zhang X, He M, Su Y, Zhao Z, Li C, Xiao R, Han Y, Zhang S, Liu Z, Lin J, Chen G, Li Y, Zhong Q (2025) Persistent activation of TRPM4 triggers necrotic cell death characterized by sodium overload. Nat Chem Biol. https:\/\/doi.org\/10.1038\/s41589-025-01841-3","journal-title":"Nat Chem Biol"},{"key":"4497_CR48","doi-asserted-by":"crossref","first-page":"e2407793","DOI":"10.1002\/adma.202407793","volume":"36","author":"XJ Gao","year":"2024","unstructured":"Gao XJ, Ciura K, Ma Y, Mikolajczyk A, Jagiello K, Wan Y, Gao Y, Zheng J, Zhong S, Puzyn T, Gao X (2024) Toward the integration of machine learning and molecular modeling for designing drug delivery nanocarriers. Adv Mater 36:e2407793","journal-title":"Adv Mater"},{"key":"4497_CR49","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41392-025-02192-0","volume":"10","author":"Z Guo","year":"2025","unstructured":"Guo Z, Chen D, Yao L, Sun Y, Li D, Le J, Dian Y, Zeng F, Chen X, Deng G (2025) The molecular mechanism and therapeutic landscape of copper and cuproptosis in cancer. Signal Transduct Target Ther 10:149","journal-title":"Signal Transduct Target Ther"},{"key":"4497_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/adtp.202300305","author":"Y Han","year":"2023","unstructured":"Han Y, Xie N, Zhou W (2023) Copper coordination-based nanomedicine for tumor theranostics. Adv Ther. https:\/\/doi.org\/10.1002\/adtp.202300305","journal-title":"Adv Ther"},{"key":"4497_CR51","doi-asserted-by":"crossref","first-page":"116570","DOI":"10.1016\/j.biopha.2024.116570","volume":"174","author":"J Han","year":"2024","unstructured":"Han J, Luo J, Wang C, Kapilevich L, Zhang XA (2024a) Roles and mechanisms of copper homeostasis and cuproptosis in osteoarticular diseases. Biomed Pharmacother 174:116570","journal-title":"Biomed Pharmacother"},{"key":"4497_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/adtp.202300305","author":"Y Han","year":"2024","unstructured":"Han Y, Xie N, Zhou W (2024b) Copper coordination-based nanomedicine for tumor theranostics. Adv Ther. https:\/\/doi.org\/10.1002\/adtp.202300305","journal-title":"Adv Ther"},{"key":"4497_CR53","doi-asserted-by":"crossref","unstructured":"Hao, C., Huang, L., Zhang, H., Xu, L., Sun, M., Kuang, H., Wang, Q. & C. H, X (2023) Chiral CuxOS@Fe\u2010MOFs for enhanced cancer therapy. Adv Funct Mater 34","DOI":"10.1002\/adfm.202312795"},{"key":"4497_CR54","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s11671-024-04118-1","volume":"19","author":"U Havelikar","year":"2024","unstructured":"Havelikar U, Ghorpade KB, Kumar A, Patel A, Singh M, Banjare N, Gupta PN (2024) Comprehensive insights into mechanism of nanotoxicity, assessment methods and regulatory challenges of nanomedicines. Discov Nano 19:165","journal-title":"Discov Nano"},{"key":"4497_CR55","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1080\/1061186X.2024.2393417","volume":"32","author":"S Heydari","year":"2024","unstructured":"Heydari S, Masoumi N, Esmaeeli E, Ayyoubzadeh SM, Ghorbani-Bidkorpeh F, Ahmadi M (2024) Artificial intelligence in nanotechnology for treatment of diseases. J Drug Target 32:1247\u20131266","journal-title":"J Drug Target"},{"key":"4497_CR56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2018.12.028","volume":"85","author":"P Huang","year":"2019","unstructured":"Huang P, Wang X, Liang X, Yang J, Zhang C, Kong D, Wang W (2019) Nano-, micro-, and macroscale drug delivery systems for cancer immunotherapy. Acta Biomater 85:1\u201326","journal-title":"Acta Biomater"},{"key":"4497_CR57","doi-asserted-by":"crossref","first-page":"963639","DOI":"10.3389\/fmolb.2023.963639","volume":"10","author":"W Huang","year":"2023","unstructured":"Huang W, Wu Y, Zhu J, Luo N, Wang C, Liu S, Cheng Z (2023) Pan-cancer integrated bioinformatics analysis reveals cuproptosis related gene FDX1 is a potential prognostic and immunotherapeutic biomarker for lower-grade gliomas. Front Mol Biosci 10:963639","journal-title":"Front Mol Biosci"},{"key":"4497_CR58","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.actbio.2024.05.035","volume":"183","author":"H Huang","year":"2024","unstructured":"Huang H, Guo H, Liu J, Ni C, Xia L, Cao X, Xia J, Shi X, Guo R (2024a) Dendrimer\/metal-phenolic nanocomplexes encapsulating CuO(2) for targeted magnetic resonance imaging and enhanced ferroptosis\/cuproptosis\/chemodynamic therapy by regulating the tumor microenvironment. Acta Biomater 183:252\u2013263","journal-title":"Acta Biomater"},{"key":"4497_CR59","doi-asserted-by":"crossref","first-page":"122701","DOI":"10.1016\/j.biomaterials.2024.122701","volume":"311","author":"L Huang","year":"2024","unstructured":"Huang L, Zhu J, Wu G, Xiong W, Feng J, Yan C, Yang J, Li Z, Fan Q, Ren B (2024b) A strategy of \u201cadding fuel to the flames\u201d enables a self-accelerating cycle of ferroptosis-cuproptosis for potent antitumor therapy. Biomaterials 311:122701","journal-title":"Biomaterials"},{"key":"4497_CR60","doi-asserted-by":"crossref","first-page":"149640","DOI":"10.1016\/j.cej.2024.149640","volume":"485","author":"M Ji","year":"2024","unstructured":"Ji M, Liu H, Liang X, Wei M, Shi D, Gou J, Yin T, He H, Tang X, Zhang Y (2024) Tumor cells are under siege from all sides: tumor cell-mimic metal\u2212 organic framework nanoparticles triggering cuproptosis\/ferroptosis\/apoptosis for chemo-chemodynamic-photothermal-immunological synergistic antitumor therapy. Chem Eng J 485:149640","journal-title":"Chem Eng J"},{"key":"4497_CR61","doi-asserted-by":"crossref","first-page":"137147","DOI":"10.1016\/j.cej.2022.137147","volume":"446","author":"Z Jing","year":"2022","unstructured":"Jing Z, Du Q, Zhang X, Zhang Y (2022) Nanomedicines and nanomaterials for cancer therapy: progress, challenge and perspectives. Chem Eng J 446:137147","journal-title":"Chem Eng J"},{"key":"4497_CR62","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.jcis.2025.02.186","volume":"688","author":"Q Jing","year":"2025","unstructured":"Jing Q, Zhang JL, Yuan LL, Zhang HX, Lin WQ, Pei D, Di DL, Yang LC, Fan ZX, Hai J (2025) Copper-based hollow mesoporous nanogenerator with reactive oxygen species and reactive nitrogen species storm generation for self-augmented immunogenic cell death-mediated triple-negative breast cancer immunotherapy. J Colloid Interface Sci 688:688\u2013702","journal-title":"J Colloid Interface Sci"},{"key":"4497_CR63","doi-asserted-by":"crossref","unstructured":"Joshi, M A (2014) Bibliometric indicators for evaluating the quality of scientifc publications. J Contemp Dent Pract 15: 258\u201362","DOI":"10.5005\/jp-journals-10024-1525"},{"key":"4497_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15061567","author":"X Kang","year":"2023","unstructured":"Kang X, Jadhav S, Annaji M, Huang CH, Amin R, Shen J, Ashby CR JR., Tiwari AK, Babu RJ, Chen P (2023) Advancing cancer therapy with copper\/disulfiram nanomedicines and drug delivery systems. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics15061567","journal-title":"Pharmaceutics"},{"key":"4497_CR65","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1039\/C8NH00417J","volume":"4","author":"L Kong","year":"2019","unstructured":"Kong L, Campbell F, Kros A (2019) DePEGylation strategies to increase cancer nanomedicine efficacy. Nanoscale Horiz 4:378\u2013387","journal-title":"Nanoscale Horiz"},{"key":"4497_CR66","first-page":"4616","volume":"72","author":"MT Kuo","year":"2012","unstructured":"Kuo MT, Fu S, Savaraj N, Chen HH (2012) Role of the human high-affinity copper transporter in copper homeostasis regulation and cisplatin sensitivity in cancer chemotherapy. Cancer Res 72:4616\u20134621","journal-title":"Cancer Res"},{"key":"4497_CR67","doi-asserted-by":"crossref","unstructured":"Li, C. J., Tzeng, Y. T., Chiu, Y. H., Lin, H. Y., Hou, M. F. & Chu, P Y (2021) Pathogenesis and potential therapeutic targets for triple-negative breast cancer. Cancers (Basel) 13","DOI":"10.3390\/cancers13122978"},{"key":"4497_CR68","doi-asserted-by":"crossref","first-page":"1135181","DOI":"10.3389\/fendo.2023.1135181","volume":"14","author":"D Li","year":"2023","unstructured":"Li D, Gao Z, Li Q, Liu X, Liu H (2023a) Cuproptosis-a potential target for the treatment of osteoporosis. Front Endocrinol (Lausanne) 14:1135181","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4497_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2023.144951","author":"X Li","year":"2023","unstructured":"Li X, Cui Y, Zhou T, Li J, Lu P, Yuwen L, Wang L, Weng L (2023b) Nanomedicine targets endogenous copper ions for disease diagnosis and therapy. Chem Eng J. https:\/\/doi.org\/10.1016\/j.cej.2023.144951","journal-title":"Chem Eng J"},{"key":"4497_CR70","doi-asserted-by":"crossref","first-page":"58203","DOI":"10.1021\/acsami.4c10336","volume":"16","author":"W Li","year":"2024","unstructured":"Li W, Wang H, Liu Y, Li B, Wang F, Ye P, Xu Y, Lai Y, Yang T (2024a) \u201cTrinity\u201d Comprehensively Regulates the Tumor Microenvironment of Lipid-Coated CaCO(3)@CuO(2) Nanoparticles Induces \u201cCuproptosis\u201d in HCC. ACS Appl Mater Interfaces 16:58203\u201358216","journal-title":"ACS Appl Mater Interfaces"},{"key":"4497_CR71","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202310309","author":"Y Li","year":"2024","unstructured":"Li Y, Liu J, Chen Y, Weichselbaum RR, Lin W (2024b) Nanoparticles synergize ferroptosis and cuproptosis to potentiate cancer immunotherapy. Adv Sci. https:\/\/doi.org\/10.1002\/advs.202310309","journal-title":"Adv Sci"},{"key":"4497_CR72","doi-asserted-by":"crossref","first-page":"122805","DOI":"10.1016\/j.biomaterials.2024.122805","volume":"313","author":"SR Li","year":"2025","unstructured":"Li SR, Tao SY, Li Q, Hu CY, Sun ZJ (2025a) Harnessing nanomaterials for copper-induced cell death. Biomaterials 313:122805","journal-title":"Biomaterials"},{"key":"4497_CR73","doi-asserted-by":"crossref","first-page":"117814","DOI":"10.1016\/j.biopha.2025.117814","volume":"183","author":"Y Li","year":"2025","unstructured":"Li Y, Han Y, Shu Q, Kan YK, Wang Z (2025b) Cuproptosis and copper as potential mechanisms and intervention targets in Alzheimer\u2019s disease. Biomed Pharmacother 183:117814","journal-title":"Biomed Pharmacother"},{"key":"4497_CR74","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.tibs.2024.04.002","volume":"49","author":"CH Lin","year":"2024","unstructured":"Lin CH, Chin Y, Zhou M, Sobol RW, Hung MC, Tan M (2024a) Protein lipoylation: mitochondria, cuproptosis, and beyond. Trends Biochem Sci 49:729\u2013744","journal-title":"Trends Biochem Sci"},{"key":"4497_CR75","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1021\/acs.molpharmaceut.4c00097","volume":"21","author":"W Lin","year":"2024","unstructured":"Lin W, Li A, Qiu L, Huang H, Cui P, Wang J (2024b) Albumin nanoparticles increase the efficacy of doxorubicin hydrochloride liposome injection based on threshold theory. Mol Pharm 21:2970\u20132980","journal-title":"Mol Pharm"},{"key":"4497_CR76","doi-asserted-by":"crossref","unstructured":"Lin Y, Lin W, Lai Y, Chen Y (2024c) Trends of copper homeostasis in neoplasms: a systemic bibliometric from 2013 to 2023.\u00a0Biol Trace Elem Res 6:3445\u20133454","DOI":"10.1007\/s12011-024-04413-z"},{"key":"4497_CR77","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12951-023-02033-8","volume":"21","author":"LX Ling","year":"2023","unstructured":"Ling LX, Ouyang Y, Hu Y (2023) Research trends on nanomaterials in gastric cancer: a bibliometric analysis from 2004 to 2023. J Nanobiotechnology 21:248","journal-title":"J Nanobiotechnology"},{"key":"4497_CR78","doi-asserted-by":"crossref","first-page":"117725","DOI":"10.1016\/j.ecoenv.2025.117725","volume":"290","author":"W Ling","year":"2025","unstructured":"Ling W, Li S, Zhu Y, Wang X, Jiang D, Kang B (2025) Inducers of autophagy and cell death: focus on copper metabolism. Ecotoxicol Environ Saf 290:117725","journal-title":"Ecotoxicol Environ Saf"},{"key":"4497_CR79","doi-asserted-by":"crossref","first-page":"116115","DOI":"10.1016\/j.biopha.2023.116115","volume":"171","author":"N Liu","year":"2024","unstructured":"Liu N, Chen M (2024) Crosstalk between ferroptosis and cuproptosis: from mechanism to potential clinical application. Biomed Pharmacother 171:116115","journal-title":"Biomed Pharmacother"},{"key":"4497_CR80","doi-asserted-by":"crossref","first-page":"7926","DOI":"10.1038\/s41598-023-34752-1","volume":"13","author":"Z Liu","year":"2023","unstructured":"Liu Z, Miao J (2023) Prognostic and immunological role of FDX1 in pan-cancer: an in-silico analysis. Sci Rep 13:7926","journal-title":"Sci Rep"},{"key":"4497_CR81","doi-asserted-by":"crossref","first-page":"1451067","DOI":"10.3389\/fphar.2024.1451067","volume":"15","author":"X Liu","year":"2024","unstructured":"Liu X, Zhang W, Wei S, Liang X, Luo B (2024a) Targeting cuproptosis with nano material: new way to enhancing the efficacy of immunotherapy in colorectal cancer. Front Pharmacol 15:1451067","journal-title":"Front Pharmacol"},{"key":"4497_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2024.153373","author":"Y Liu","year":"2024","unstructured":"Liu Y, Chen G, You X, Wang X (2024b) Cuproptosis nanomedicine: clinical challenges and opportunities for anti-tumor therapy. Chem Eng J. https:\/\/doi.org\/10.1016\/j.cej.2024.153373","journal-title":"Chem Eng J"},{"key":"4497_CR83","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2147\/IJN.S504629","volume":"20","author":"Y Liu","year":"2025","unstructured":"Liu Y, Si L, Jiang Y, Jiang S, Zhang X, Li S, Chen J, Hu J (2025) Design of pH-responsive nanomaterials based on the tumor microenvironment. Int J Nanomed 20:705\u2013721","journal-title":"Int J Nanomed"},{"key":"4497_CR84","doi-asserted-by":"crossref","first-page":"e2400652","DOI":"10.1002\/adhm.202400652","volume":"13","author":"J Lu","year":"2024","unstructured":"Lu J, Miao Y, Li Y (2024a) Cuproptosis: advances in stimulus-responsive nanomaterials for cancer therapy. Adv Healthc Mater 13:e2400652","journal-title":"Adv Healthc Mater"},{"key":"4497_CR85","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202309984","author":"XF Lu","year":"2024","unstructured":"Lu XF, Chen XD, Lin CY, Yi YD, Zhao SS, Zhu BZ, Deng WH, Wang X, Xie ZL, Rao SR, Ni ZL, You T, Li LY, Huang YP, Xue XY, Yu YJ, Sun WJ, Shen X (2024b) Elesclomol loaded copper oxide nanoplatform triggers cuproptosis to enhance antitumor immunotherapy. Adv Sci. https:\/\/doi.org\/10.1002\/advs.202309984","journal-title":"Adv Sci"},{"key":"4497_CR86","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202416285","author":"XW Luan","year":"2025","unstructured":"Luan XW, Du SY, Liu ZY, He BS, Pan YC, Yang J, Li YY, Kong DS, Han X, Song YJ (2025) Microneedle-loaded gene-editable nanohybrids engineer cancer cells by telomere stress induction and metabolic interference for enhanced cuproptosis and immunotherapy. Adv Funct Mater. https:\/\/doi.org\/10.1002\/adfm.202416285","journal-title":"Adv Funct Mater"},{"key":"4497_CR87","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.cbpa.2010.01.003","volume":"14","author":"S Lutsenko","year":"2010","unstructured":"Lutsenko S (2010) Human copper homeostasis: a network of interconnected pathways. Curr Opin Chem Biol 14:211\u2013217","journal-title":"Curr Opin Chem Biol"},{"issue":"8068","key":"4497_CR88","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/d41586-025-01750-4","volume":"642","author":"S Mallapaty","year":"2025","unstructured":"Mallapaty S (2025) How China is vying to attract the world\u2019s top scientific talent. Nature 642:556","journal-title":"Nature"},{"key":"4497_CR89","doi-asserted-by":"publisher","DOI":"10.1039\/D5CS00083A","author":"L Mao","year":"2025","unstructured":"Mao L, Lu J, Wen X, Song Z, Sun C, Zhao Y, Huang F, Chen S, Jiang D, Che W, Zhong C, Yu C, Li K, Lu X, Shi J (2025) Cuproptosis: mechanisms and nanotherapeutic strategies in cancer and beyond. Chem Soc Rev. https:\/\/doi.org\/10.1039\/D5CS00083A","journal-title":"Chem Soc Rev"},{"key":"4497_CR90","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.cmet.2012.05.001","volume":"15","author":"I Marin-Valencia","year":"2012","unstructured":"Marin-Valencia I, Yang C, Mashimo T, Cho S, Baek H, Yang XL, Rajagopalan KN, Maddie M, Vemireddy V, Zhao Z, Cai L, Good L, Tu BP, Hatanpaa KJ, Mickey BE, MAT\u00e9S JM, Pascual JM, Maher EA, Malloy CR, Deberardinis RJ, Bachoo RM (2012) Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo. Cell Metab 15:827\u2013837","journal-title":"Cell Metab"},{"key":"4497_CR91","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/17425247.2024.2440618","volume":"22","author":"H Mazumdar","year":"2025","unstructured":"Mazumdar H, Khondakar KR, Das S, Halder A, Kaushik A (2025) Artificial intelligence for personalized nanomedicine; from material selection to patient outcomes. Expert Opin Drug Deliv 22:85\u2013108","journal-title":"Expert Opin Drug Deliv"},{"key":"4497_CR92","doi-asserted-by":"publisher","DOI":"10.1002\/adtp.202400426","author":"I Mehmud","year":"2025","unstructured":"Mehmud I, Wu S, Zhang S (2025) The role of copper ions in mediating the anti-cancer effects using nanomaterials. Adv Ther. https:\/\/doi.org\/10.1002\/adtp.202400426","journal-title":"Adv Ther"},{"key":"4497_CR93","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.omega.2016.12.004","volume":"73","author":"JM Merig\u00f3","year":"2017","unstructured":"Merig\u00f3 JM, Yang J-B (2017) A bibliometric analysis of operations research and management science. Omega 73:37\u201348","journal-title":"Omega"},{"key":"4497_CR94","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41420-023-01421-1","volume":"9","author":"YD Miao","year":"2023","unstructured":"Miao YD, Quan W, Dong X, Gan J, Ji CF, Wang JT, Zhang F (2023) A bibliometric analysis of ferroptosis, necroptosis, pyroptosis, and cuproptosis in cancer from 2012 to 2022. Cell Death Discov 9:129","journal-title":"Cell Death Discov"},{"key":"4497_CR95","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1016\/j.xphs.2017.06.019","volume":"106","author":"AA Natfji","year":"2017","unstructured":"Natfji AA, Ravishankar D, Osborn HMI, Greco F (2017) Parameters affecting the enhanced permeability and retention effect: the need for patient selection. J Pharm Sci 106:3179\u20133187","journal-title":"J Pharm Sci"},{"key":"4497_CR96","doi-asserted-by":"crossref","first-page":"0094","DOI":"10.34133\/bmr.0094","volume":"28","author":"D Noh","year":"2024","unstructured":"Noh D, Lee H, Lee S, Sun IC, Yoon HY (2024) Copper-based nanomedicines for cuproptosis-mediated effective cancer treatment. Biomater Res 28:0094","journal-title":"Biomater Res"},{"key":"4497_CR97","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15020495","author":"L Noorain","year":"2023","unstructured":"Noorain L, Nguyen V, Kim HW, Nguyen LTB (2023) A machine learning approach for PLGA nanoparticles in antiviral drug delivery. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics15020495","journal-title":"Pharmaceutics"},{"key":"4497_CR98","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1515\/hsz-2018-0327","volume":"400","author":"E Obrador","year":"2019","unstructured":"Obrador E, Liu-Smith F, Dellinger RW, Salvador R, Meyskens FL, Estrela JM (2019) Oxidative stress and antioxidants in the pathophysiology of malignant melanoma. Biol Chem 400:589\u2013612","journal-title":"Biol Chem"},{"key":"4497_CR99","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jconrel.2022.10.023","volume":"352","author":"Z Pei","year":"2022","unstructured":"Pei Z, Chen S, Ding L, Liu J, Cui X, Li F, Qiu F (2022) Current perspectives and trend of nanomedicine in cancer: a review and bibliometric analysis. J Control Release 352:211\u2013241","journal-title":"J Control Release"},{"key":"4497_CR100","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.tips.2017.04.005","volume":"38","author":"P Poprac","year":"2017","unstructured":"Poprac P, Jomova K, Simunkova M, Kollar V, Rhodes CJ, Valko M (2017) Targeting free radicals in oxidative stress-related human diseases. Trends Pharmacol Sci 38:592\u2013607","journal-title":"Trends Pharmacol Sci"},{"key":"4497_CR101","doi-asserted-by":"crossref","first-page":"110943","DOI":"10.1016\/j.cbi.2024.110943","volume":"393","author":"Z Qiu","year":"2024","unstructured":"Qiu Z, Liu Q, Wang L, Xiong Y, Wu J, Wang M, Yan X, Deng H (2024) The copper transporter, SLC31A1, transcriptionally activated by ELF3, imbalances copper homeostasis to exacerbate cisplatin-induced acute kidney injury through mitochondrial dysfunction. Chem Biol Interact 393:110943","journal-title":"Chem Biol Interact"},{"key":"4497_CR102","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jhip.2025.03.007","volume":"6","author":"MV Rajesh","year":"2025","unstructured":"Rajesh MV, Elumalai K (2025) The transformative power of artificial intelligence in pharmaceutical manufacturing: enhancing efficiency, product quality, and safety. J Holist Integr Pharm 6:125\u2013135","journal-title":"J Holist Integr Pharm"},{"key":"4497_CR103","volume":"101","author":"X Ren","year":"2022","unstructured":"Ren X, Pan C, Pan Z, Zhao S, Wu C, Chen W, Liu M, Han X, Kuang H, Qu M (2022a) Knowledge mapping of copper-induced cell death: a bibliometric study from 2012 to 2022. Medicine (Baltimore) 101:e31133","journal-title":"Medicine (Baltimore)"},{"key":"4497_CR104","doi-asserted-by":"publisher","DOI":"10.3390\/ma15155290","author":"Z Ren","year":"2022","unstructured":"Ren Z, Liao T, Li C, Kuang Y (2022b) Drug delivery systems with a \u201ctumor-triggered\u201d targeting or intracellular drug release property based on DePEGylation. Materials. https:\/\/doi.org\/10.3390\/ma15155290","journal-title":"Materials"},{"key":"4497_CR105","doi-asserted-by":"crossref","first-page":"2302537","DOI":"10.1002\/adhm.202302537","volume":"13","author":"Y Ruan","year":"2024","unstructured":"Ruan Y, Zhuang H, Zeng X, Lin L, Wang X, Xue P, Xu S, Chen Q, Yan S, Huang W (2024) Engineered microbial nanohybrids for tumor-mediated NIR II photothermal enhanced ferroptosis\/cuproptosis and immunotherapy. Adv Healthc Mater 13:2302537","journal-title":"Adv Healthc Mater"},{"key":"4497_CR106","doi-asserted-by":"crossref","first-page":"e2412462","DOI":"10.1002\/smll.202412462","volume":"21","author":"SS Sahoo","year":"2025","unstructured":"Sahoo SS, Manna D (2025) Nanomaterial-triggered ferroptosis and cuproptosis in cancer therapy. Small 21:e2412462","journal-title":"Small"},{"key":"4497_CR107","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.bbrc.2015.08.023","volume":"468","author":"V Sainz","year":"2015","unstructured":"Sainz V, Conniot J, Matos AI, Peres C, Zupancic E, Moura L, Silva LC, Florindo HF, Gaspar RS (2015) Regulatory aspects on nanomedicines. Biochem Biophys Res Commun 468:504\u2013510","journal-title":"Biochem Biophys Res Commun"},{"key":"4497_CR108","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ana.10276","volume":"52","author":"CT Sheline","year":"2002","unstructured":"Sheline CT, Choi EH, Kim-Han JS, Dugan LL, Choi DW (2002) Cofactors of mitochondrial enzymes attenuate copper-induced death in vitro and in vivo. Ann Neurol 52:195\u2013204","journal-title":"Ann Neurol"},{"key":"4497_CR109","doi-asserted-by":"crossref","first-page":"1172262","DOI":"10.3389\/fimmu.2023.1172262","volume":"14","author":"C Shen","year":"2023","unstructured":"Shen C, Zhang ZJ, Li XX, Huang YP, Wang YX, Zhou H, Xiong L, Wen Y, Zou H, Liu ZT (2023) Intersection of nanomaterials and organoids technology in biomedicine. Front Immunol 14:1172262","journal-title":"Front Immunol"},{"key":"4497_CR110","doi-asserted-by":"crossref","first-page":"e202400216","DOI":"10.1002\/cmdc.202400216","volume":"19","author":"Z Shen","year":"2024","unstructured":"Shen Z, Qiu Y, Ding H, Ren F, Chen H (2024) Cuproptosis and cuproptosis-based synergistic therapy for cancer treatment. ChemMedChem 19:e202400216","journal-title":"ChemMedChem"},{"key":"4497_CR111","first-page":"38","volume":"7","author":"J Shi","year":"2024","unstructured":"Shi J, Shen Y, Zhang J (2024a) Emerging roles of small extracellular vesicles in metabolic reprogramming and drug resistance in cancers. Cancer Drug Resist 7:38","journal-title":"Cancer Drug Resist"},{"key":"4497_CR112","doi-asserted-by":"crossref","first-page":"33276","DOI":"10.1021\/acsnano.4c13330","volume":"18","author":"Y Shi","year":"2024","unstructured":"Shi Y, Han X, Zou S, Liu G (2024b) Nanomaterials in organoids: from interactions to personalized medicine. ACS Nano 18:33276\u201333292","journal-title":"ACS Nano"},{"key":"4497_CR113","doi-asserted-by":"crossref","first-page":"104653","DOI":"10.1016\/j.critrevonc.2025.104653","volume":"208","author":"M Shirzad","year":"2025","unstructured":"Shirzad M, Salahvarzi A, Razzaq S, Javid-Naderi MJ, Rahdar A, Fathi-Karkan S, Ghadami A, Kharaba Z, Romanholo Ferreira LF (2025) Revolutionizing prostate cancer therapy: artificial intelligence\u2014based nanocarriers for precision diagnosis and treatment. Crit Rev Oncol Hematol 208:104653","journal-title":"Crit Rev Oncol Hematol"},{"key":"4497_CR114","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1021\/acsbiomaterials.4c00586","volume":"10","author":"Y Song","year":"2024","unstructured":"Song Y, Tan KB, Zhou SF, Zhan G (2024) Biocompatible copper-based nanocomposites for combined cancer therapy. ACS Biomater Sci Eng 10:3673\u20133692","journal-title":"ACS Biomater Sci Eng"},{"key":"4497_CR115","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/mdb2.70001","volume":"1","author":"S Song","year":"2025","unstructured":"Song S, Liu Z, Wang Y, Gong B (2025) Human organoids and their application in tumor models, disease modeling, and tissue engineering. Medicine Bulletin 1:17\u201336","journal-title":"Medicine Bulletin"},{"key":"4497_CR116","doi-asserted-by":"crossref","first-page":"e2301470","DOI":"10.1002\/smtd.202301470","volume":"8","author":"T Su","year":"2024","unstructured":"Su T, Zhao F, Ying Y, Li W, Li J, Zheng J, Qiao L, Che S, Yu J (2024) Self-monitoring theranostic nanomaterials: emerging visual agents for real-time monitoring of tumor treatment processes. Small Methods 8:e2301470","journal-title":"Small Methods"},{"key":"4497_CR117","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41422-022-00653-7","volume":"32","author":"D Tang","year":"2022","unstructured":"Tang D, Chen X, Kroemer G (2022) Cuproptosis: a copper-triggered modality of mitochondrial cell death. Cell Res 32:417\u2013418","journal-title":"Cell Res"},{"key":"4497_CR118","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/s41571-024-00876-0","volume":"21","author":"D Tang","year":"2024","unstructured":"Tang D, Kroemer G, Kang R (2024) Targeting cuproplasia and cuproptosis in cancer. Nat Rev Clin Oncol 21:370\u2013388","journal-title":"Nat Rev Clin Oncol"},{"key":"4497_CR119","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1177\/0165551507087238","volume":"34","author":"M Thelwall","year":"2008","unstructured":"Thelwall M (2008) Bibliometrics to webometrics. J Inf Sci 34:605\u2013621","journal-title":"J Inf Sci"},{"key":"4497_CR120","doi-asserted-by":"crossref","first-page":"999849","DOI":"10.3389\/fimmu.2022.999849","volume":"13","author":"XM Tian","year":"2022","unstructured":"Tian XM, Xiang B, Yu YH, Li Q, Zhang ZX, Zhanghuang C, Jin LM, Wang JK, Mi T, Chen ML, Liu F, Wei GH (2022) A novel cuproptosis-related subtypes and gene signature associates with immunophenotype and predicts prognosis accurately in neuroblastoma. Front Immunol 13:999849","journal-title":"Front Immunol"},{"key":"4497_CR121","doi-asserted-by":"crossref","first-page":"122223","DOI":"10.1016\/j.lfs.2023.122223","volume":"334","author":"Z Tian","year":"2023","unstructured":"Tian Z, Jiang S, Zhou J, Zhang W (2023) Copper homeostasis and cuproptosis in mitochondria. Life Sci 334:122223","journal-title":"Life Sci"},{"key":"4497_CR122","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13045-022-01392-3","volume":"15","author":"X Tong","year":"2022","unstructured":"Tong X, Tang R, Xiao M, Xu J, Wang W, Zhang B, Liu J, Yu X, Shi S (2022) Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research. J Hematol Oncol 15:174","journal-title":"J Hematol Oncol"},{"key":"4497_CR123","doi-asserted-by":"crossref","first-page":"R421","DOI":"10.1016\/j.cub.2021.03.054","volume":"31","author":"T Tsang","year":"2021","unstructured":"Tsang T, Davis CI, Brady DC (2021) Copper biology. Curr Biol 31:R421-r427","journal-title":"Curr Biol"},{"key":"4497_CR124","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41589-019-0291-9","volume":"15","author":"P Tsvetkov","year":"2019","unstructured":"Tsvetkov P, Detappe A, Cai K, Keys HR, Brune Z, Ying W, Thiru P, Reidy M, Kugener G, Rossen J, Kocak M, Kory N, Tsherniak A, Santagata S, Whitesell L, Ghobrial IM, Markley JL, Lindquist S, Golub TR (2019) Mitochondrial metabolism promotes adaptation to proteotoxic stress. Nat Chem Biol 15:681\u2013689","journal-title":"Nat Chem Biol"},{"key":"4497_CR125","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, Abdusamad M, Rossen J, Joesch-Cohen L, Humeidi R, Spangler RD, Eaton JK, Frenkel E, Kocak M, Corsello SM, Lutsenko S, Kanarek N, Santagata S, Golub TR (2022) Copper induces cell death by targeting lipoylated TCA cycle proteins. Science 375:1254\u20131261","journal-title":"Science"},{"key":"4497_CR126","doi-asserted-by":"crossref","first-page":"114196","DOI":"10.1016\/j.colsurfb.2024.114196","volume":"245","author":"Y Wan","year":"2025","unstructured":"Wan Y, Chen J, Li J, Chen Z, Wang Y, Li J, Pei Z, Pei Y (2025) Cu0-based nanoparticles boost anti-tumor efficacy via synergy of cuproptosis and ferroptosis enhanced by cuproptosis-induced glutathione synthesis disorder. Colloids Surf B Biointerfaces 245:114196","journal-title":"Colloids Surf B Biointerfaces"},{"key":"4497_CR127","doi-asserted-by":"crossref","first-page":"114830","DOI":"10.1016\/j.biopha.2023.114830","volume":"163","author":"D Wang","year":"2023","unstructured":"Wang D, Tian Z, Zhang P, Zhen L, Meng Q, Sun B, Xu X, Jia T, Li S (2023a) The molecular mechanisms of cuproptosis and its relevance to cardiovascular disease. Biomed Pharmacother 163:114830","journal-title":"Biomed Pharmacother"},{"key":"4497_CR128","doi-asserted-by":"crossref","unstructured":"Wang, J., Zhao, W., Zhang, Z., Liu, X., Xie, T., Wang, L., Xue, Y. & Zhang, Y (2023b) A journey of challenges and victories: a bibliometric worldview of nanomedicine since the 21st Century. Adv Mater e2308915","DOI":"10.1002\/adma.202308915"},{"key":"4497_CR129","doi-asserted-by":"crossref","first-page":"19581","DOI":"10.1021\/acsnano.3c07775","volume":"17","author":"W Wang","year":"2023","unstructured":"Wang W, Mo W, Hang Z, Huang Y, Yi H, Sun Z, Lei A (2023c) Cuproptosis: harnessing transition metal for cancer therapy. ACS Nano 17:19581\u201319599","journal-title":"ACS Nano"},{"key":"4497_CR130","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2024.5441","author":"J Wang","year":"2024","unstructured":"Wang J, Zou Y, Guan R, Tan S, Su L, Zhao Z, Cao Z, Jiang K, Wang T, Zheng G (2024a) Copper supplementation alleviates hypoxia-induced ferroptosis and oxidative stress in neuronal cells. Int J Mol Med. https:\/\/doi.org\/10.3892\/ijmm.2024.5441","journal-title":"Int J Mol Med"},{"key":"4497_CR131","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202401646","author":"N Wang","year":"2024","unstructured":"Wang N, Liu YC, Peng DZ, Zhang QY, Zhang ZB, Xu LN, Yin LH, Zhao XR, Lu Z, Peng JY (2024b) Copper-based composites nanoparticles improve triple-negative breast cancer treatment with induction of apoptosis-cuproptosis and immune activation. Adv Healthc Mater. https:\/\/doi.org\/10.1002\/adhm.202401646","journal-title":"Adv Healthc Mater"},{"key":"4497_CR132","first-page":"6","volume":"1","author":"S Wang","year":"2024","unstructured":"Wang S, Ma R, Mei Z, Hou Y (2024c) Metalloptosis: metal ions-induced programmed cell death based on nanomaterials for cancer therapy. Med Math 1:6\u201326","journal-title":"Med Math"},{"key":"4497_CR133","doi-asserted-by":"crossref","first-page":"6253","DOI":"10.2147\/IJN.S459710","volume":"19","author":"Y Wang","year":"2024","unstructured":"Wang Y, Deng T, Liu X, Fang X, Mo Y, Xie N, Nie G, Zhang B, Fan X (2024d) Smart nanoplatforms responding to the tumor microenvironment for precise drug delivery in cancer therapy. Int J Nanomedicine 19:6253\u20136277","journal-title":"Int J Nanomedicine"},{"key":"4497_CR134","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1186\/s12951-024-02968-6","volume":"22","author":"Y Wang","year":"2024","unstructured":"Wang Y, Zhou Q, Luo W, Yang X, Zhang J, Lou Y, Mao J, Chen J, Wu F, Hou J, Tang G, Bai H, Yu R (2024e) A collagenase-decorated Cu-based nanotheranostics: remodeling extracellular matrix for optimizing cuproptosis and MRI in pancreatic ductal adenocarcinoma. J Nanobiotechnology 22:689","journal-title":"J Nanobiotechnology"},{"key":"4497_CR135","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2024.216284","author":"L Wang","year":"2025","unstructured":"Wang L, Piao J, Qi H, Qiao C, Guo Q, Wei M, Li Z (2025) Cuproptosis nanomedicine in cancer therapy: novel insights and future perspectives. Coord Chem Rev. https:\/\/doi.org\/10.1016\/j.ccr.2024.216284","journal-title":"Coord Chem Rev"},{"key":"4497_CR136","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41596-021-00658-3","volume":"17","author":"S Watanabe","year":"2022","unstructured":"Watanabe S, Kobayashi S, Ogasawara N, Okamoto R, Nakamura T, Watanabe M, Jensen KB, Yui S (2022) Transplantation of intestinal organoids into a mouse model of colitis. Nat Protoc 17:649\u2013671","journal-title":"Nat Protoc"},{"key":"4497_CR137","doi-asserted-by":"crossref","unstructured":"Wei, C. & Fu, Q (2023) Cell death mediated by nanotechnology via the cuproptosis pathway: a novel horizon for cancer therapy. View.","DOI":"10.22541\/au.167285901.13929025\/v1"},{"key":"4497_CR138","doi-asserted-by":"crossref","first-page":"149040","DOI":"10.1016\/j.cej.2024.149040","volume":"483","author":"Q Wei","year":"2024","unstructured":"Wei Q, Pan Y, Zhang Z, Yan S, Li Z (2024a) Copper-based nanomaterials for biomedical applications. Chem Eng J 483:149040","journal-title":"Chem Eng J"},{"key":"4497_CR139","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jhip.2024.12.002","volume":"5","author":"W Wei","year":"2024","unstructured":"Wei W, Song C, Qi C, Zhang X, Zhang X, Pu R, Ao Y (2024b) Visual analysis of drug research and development based on artificial intelligence. J Holist Integr Pharm 5:323\u2013332","journal-title":"J Holist Integr Pharm"},{"key":"4497_CR140","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41420-023-01542-7","volume":"9","author":"H Wu","year":"2023","unstructured":"Wu H, Cheng K, Li C (2023a) Ferroptosis, necroptosis, pyroptosis, and cuproptosis in cancer: a comparative bibliometric analysis. Cell Death Discov 9:238","journal-title":"Cell Death Discov"},{"key":"4497_CR141","doi-asserted-by":"crossref","first-page":"216348","DOI":"10.1016\/j.canlet.2023.216348","volume":"571","author":"Z Wu","year":"2023","unstructured":"Wu Z, Lv G, Xing F, Xiang W, Ma Y, Feng Q, Yang W, Wang H (2023b) Copper in hepatocellular carcinoma: a double-edged sword with therapeutic potentials. Cancer Lett 571:216348","journal-title":"Cancer Lett"},{"key":"4497_CR142","doi-asserted-by":"crossref","first-page":"0335","DOI":"10.34133\/research.0335","volume":"7","author":"C Xiao","year":"2024","unstructured":"Xiao C, Li J, Hua A, Wang X, Li S, Li Z, Xu C, Zhang Z, Yang X, Li Z (2024) Hyperbaric oxygen boosts antitumor efficacy of copper-diethyldithiocarbamate nanoparticles against pancreatic ductal adenocarcinoma by regulating cancer stem cell metabolism. Research 7:0335","journal-title":"Research"},{"key":"4497_CR143","doi-asserted-by":"crossref","first-page":"e34020","DOI":"10.1097\/MD.0000000000034020","volume":"102","author":"X Xie","year":"2023","unstructured":"Xie X, Liu L (2023) Global status and research trends of cuprotosis research: a bibliometrics study via CiteSpace. Medicine (Baltimore) 102:e34020","journal-title":"Medicine (Baltimore)"},{"key":"4497_CR144","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12943-023-01732-y","volume":"22","author":"J Xie","year":"2023","unstructured":"Xie J, Yang Y, Gao Y, He J (2023) Cuproptosis: mechanisms and links with cancers. Mol Cancer 22:46","journal-title":"Mol Cancer"},{"key":"4497_CR145","unstructured":"Xu, S. B. & Hu, G (2024) Rethinking the author name ambiguity problem and beyond: The case of the Chinese context. Account Res 1\u201324"},{"key":"4497_CR146","doi-asserted-by":"crossref","first-page":"2205013","DOI":"10.1002\/adfm.202205013","volume":"32","author":"W Xu","year":"2022","unstructured":"Xu W, Qian J, Hou G, Wang T, Wang J, Wang Y, Yang L, Cui X, Suo A (2022) A hollow amorphous bimetal organic framework for synergistic cuproptosis\/ferroptosis\/apoptosis anticancer therapy via disrupting intracellular redox homeostasis and copper\/iron metabolisms. Adv Funct Mater 32:2205013","journal-title":"Adv Funct Mater"},{"key":"4497_CR147","first-page":"1","volume":"5","author":"H Xu","year":"2024","unstructured":"Xu H, Guo Z, Li M, Chaves HV, Pinto VDPT, Filho GC, Du M, Bezerra MM (2024) Copper-based nanomaterials for image-guided cancer therapy. BIO Integr 5:1\u201314","journal-title":"BIO Integr"},{"key":"4497_CR148","doi-asserted-by":"publisher","unstructured":"Xu C, Wang J-Y, Wang C-L, Wang W, Zhang Q-M, Chokkakula S, Wang N-S (2025) Current perspectives and trends of lipid metabolism in chronic kidney diseases: a bibliometric analysis. Food & Medicine Homology. https:\/\/doi.org\/10.26599\/FMH.2026.9420112","DOI":"10.26599\/FMH.2026.9420112"},{"key":"4497_CR149","doi-asserted-by":"crossref","first-page":"114165","DOI":"10.1016\/j.intimp.2025.114165","volume":"148","author":"R Xue","year":"2025","unstructured":"Xue R, Qin C, Li L, Huang L, Tang K, Chen J, Liang H, Xu H, Qin X, Yang C, Tan Q (2025) SRF\/SLC31A1 signaling promotes cuproptosis induced by celastrol in NSCLC. Int Immunopharmacol 148:114165","journal-title":"Int Immunopharmacol"},{"key":"4497_CR150","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/med4.36","volume":"1","author":"D Yadav","year":"2023","unstructured":"Yadav D, Malviya R (2023) Novel nanomaterials as photo-activated cancer diagnostics and therapy. Medicine Advances 1:190\u2013209","journal-title":"Medicine Advances"},{"key":"4497_CR151","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.tips.2023.07.004","volume":"44","author":"L Yang","year":"2023","unstructured":"Yang L, Yang P, Lip GYH, Ren J (2023a) Copper homeostasis and cuproptosis in cardiovascular disease therapeutics. Trends Pharmacol Sci 44:573\u2013585","journal-title":"Trends Pharmacol Sci"},{"key":"4497_CR152","volume":"11","author":"Q Yang","year":"2023","unstructured":"Yang Q, Zeng S, Liu W (2023b) Roles of cuproptosis-related gene DLAT in various cancers: a bioinformatic analysis and preliminary verification on pro-survival autophagy. PeerJ 11:e15019","journal-title":"PeerJ"},{"key":"4497_CR153","doi-asserted-by":"publisher","unstructured":"Yang S, Song Y, Hu Y, Chen H, Yang D, Song X (2023c) Multifaceted roles of copper Ions in anticancer nanomedicine. Adv Healthc Mater 12(23):e2300410. https:\/\/doi.org\/10.1002\/adhm.202300410","DOI":"10.1002\/adhm.202300410"},{"key":"4497_CR154","doi-asserted-by":"publisher","DOI":"10.1039\/D4TB02746A","author":"Y Yang","year":"2025","unstructured":"Yang Y, Dong C, Ma X, Wang Y, Li Z, Xu Y, Chen T, Gao C, Ye X, Wu A, Zhang X (2025) Advances in cuproptosis harnessing copper-based nanomaterials for cancer therapy. J Mater Chem B. https:\/\/doi.org\/10.1039\/D4TB02746A","journal-title":"J Mater Chem B"},{"key":"4497_CR155","doi-asserted-by":"crossref","unstructured":"Yeung, A W K (2019) Comparison between Scopus, Web of Science, PubMed and publishers for mislabelled review papers. Curr sci 116: 1909\u201314","DOI":"10.18520\/cs\/v116\/i11\/1909-1914"},{"key":"4497_CR156","doi-asserted-by":"crossref","first-page":"1122890","DOI":"10.3389\/fphar.2023.1122890","volume":"14","author":"R Yuan","year":"2023","unstructured":"Yuan R, Tan Y, Sun P-H, Qin B, Liang Z (2023) Emerging trends and research foci of berberine on tumor from 2002 to 2021: a bibliometric article of the literature from WoSCC. Front Pharmacol 14:1122890","journal-title":"Front Pharmacol"},{"key":"4497_CR157","doi-asserted-by":"publisher","DOI":"10.3390\/foods9020166","author":"XL Zhang","year":"2020","unstructured":"Zhang XL, Zheng Y, Xia ML, Wu YN, Liu XJ, Xie SK, Wu YF, Wang M (2020) Knowledge domain and emerging trends in vinegar research: a bibliometric review of the literature from WoSCC. Foods. https:\/\/doi.org\/10.3390\/foods9020166","journal-title":"Foods"},{"key":"4497_CR158","doi-asserted-by":"crossref","first-page":"917155","DOI":"10.3389\/fimmu.2022.917155","volume":"13","author":"J Zhang","year":"2022","unstructured":"Zhang J, Song L, Jia J, Tian W, Lai R, Zhang Z, Li J, Ju J, Xu H (2022) Knowledge mapping of necroptosis from 2012 to 2021: a bibliometric analysis. Front Immunol 13:917155","journal-title":"Front Immunol"},{"key":"4497_CR159","doi-asserted-by":"crossref","first-page":"e14797","DOI":"10.7717\/peerj.14797","volume":"11","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Li W, Bian Y, Li Y, Cong L (2023a) Multifaceted roles of aerobic glycolysis and oxidative phosphorylation in hepatocellular carcinoma. PeerJ 11:e14797","journal-title":"PeerJ"},{"key":"4497_CR160","doi-asserted-by":"crossref","first-page":"e2300153","DOI":"10.1002\/adhm.202300153","volume":"12","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Ding C, Sun T, Wang L, Chen C (2023b) Tumor therapy strategies based on microenvironment-specific responsive nanomaterials. Adv Healthc Mater 12:e2300153","journal-title":"Adv Healthc Mater"},{"key":"4497_CR161","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13045-024-01589-8","volume":"17","author":"C Zhang","year":"2024","unstructured":"Zhang C, Huang T, Li L (2024a) Targeting cuproptosis for cancer therapy: mechanistic insights and clinical perspectives. J Hematol Oncol 17:68","journal-title":"J Hematol Oncol"},{"key":"4497_CR162","doi-asserted-by":"crossref","first-page":"714","DOI":"10.21037\/tcr-23-1308","volume":"13","author":"G Zhang","year":"2024","unstructured":"Zhang G, Wang N, Ma S, Tao P, Cai H (2024b) Comprehensive analysis of the effects of the cuprotosis-associated gene SLC31A1 on patient prognosis and tumor microenvironment in human cancer. Transl Cancer Res 13:714\u2013737","journal-title":"Transl Cancer Res"},{"key":"4497_CR163","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1038\/s41556-024-01503-x","volume":"26","author":"H Zhang","year":"2024","unstructured":"Zhang H, Liu J, Yuan W, Zhang Q, Luo X, Li Y, Peng Y, Feng J, Liu X, Chen J, Zhou Y, Lv J, Zhou N, Ma J, Tang K, Huang B (2024c) Ammonia-induced lysosomal and mitochondrial damage causes cell death of effector CD8(+) T cells. Nat Cell Biol 26:1892\u20131902","journal-title":"Nat Cell Biol"},{"key":"4497_CR164","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202402022","author":"X Zhang","year":"2024","unstructured":"Zhang X, Zhu J, Wang S, Li S, E J, Hu J, Mou R, Ding H, Yang P, Xie R (2024d) A copper\/ferrous-engineering redox homeostasis disruptor for cuproptosis\/ferroptosis co-activated nanocatalytic therapy in liver cancer. Adv Funct Mater. https:\/\/doi.org\/10.1002\/adfm.202402022","journal-title":"Adv Funct Mater"},{"key":"4497_CR165","doi-asserted-by":"crossref","first-page":"122675","DOI":"10.1016\/j.biomaterials.2024.122675","volume":"311","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Zhang N, Xing J, Sun Y, Jin X, Shen C, Cheng L, Wang Y, Wang X (2024e) In situ hydrogel based on Cu\u2013Fe3O4 nanoclusters exploits oxidative stress and the ferroptosis\/cuproptosis pathway for chemodynamic therapy. Biomaterials 311:122675","journal-title":"Biomaterials"},{"key":"4497_CR166","doi-asserted-by":"crossref","first-page":"e70599","DOI":"10.1002\/cam4.70599","volume":"14","author":"J Zhang","year":"2025","unstructured":"Zhang J, Zhang A, Guo Y, Miao G, Liang S, Wang J, Wang J (2025a) Nanoparticle-mediated cuproptosis and photodynamic synergistic strategy: a novel horizon for cancer therapy. Cancer Med 14:e70599","journal-title":"Cancer Med"},{"key":"4497_CR167","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioadv.2025.214228","author":"YX Zhang","year":"2025","unstructured":"Zhang YX, Xie WJ, Li JC, Liang ZG, Zhou X, Tan ZH, Wu ZJ, Lin JD, Zhuo YJ, Zou F, Wen BY, Chen JW, Cai SH, Ye JH, Liang YK, Lu JM, Yang HK, Zhong WD, Yang RH (2025b) Precision targeted melanoma therapy via cuproptosis\/chemodynamic and chemotherapy: an engineering MCHS-CuMOF nanodelivery system. BIOMATERIALS ADVANCES. https:\/\/doi.org\/10.1016\/j.bioadv.2025.214228","journal-title":"BIOMATERIALS ADVANCES"},{"key":"4497_CR168","doi-asserted-by":"crossref","first-page":"e1892","DOI":"10.1002\/wnan.1892","volume":"15","author":"DK Zhao","year":"2023","unstructured":"Zhao DK, Liang J, Huang XY, Shen S, Wang J (2023) Organoids technology for advancing the clinical translation of cancer nanomedicine. Wiley Interdiscip Rev Nanomed Nanobiotechnol 15:e1892","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"4497_CR169","doi-asserted-by":"crossref","unstructured":"Zhao, F., Zhao, Z., Gao, H., Zhang, Y., Qi, J., Yu, H., Wang, C., Xu, J., Zubair Yousaf, M., Che, S. & Yu, J. 2024. Cuproptosis: an emerging domain for copper-based nanomaterials mediated cancer therapy. Med Mat, 1.","DOI":"10.1097\/mm9.0000000000000010"},{"key":"4497_CR170","doi-asserted-by":"crossref","first-page":"e1797","DOI":"10.1002\/wnan.1797","volume":"14","author":"X Zhong","year":"2022","unstructured":"Zhong X, Dai X, Wang Y, Wang H, Qian H, Wang X (2022) Copper-based nanomaterials for cancer theranostics. Wiley Interdiscip Rev Nanomed Nanobiotechnol 14:e1797","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"4497_CR171","doi-asserted-by":"crossref","first-page":"145795","DOI":"10.1016\/j.cej.2023.145795","volume":"474","author":"J Zhong","year":"2023","unstructured":"Zhong J, Zheng X, Wen Y, Wang S-B, Zhan G, Chen A-Z (2023) In situ sacrificial growth of metastable copper-enriched nanomedicine for cuproptosis-based synergistic cancer therapy. Chem Eng J 474:145795","journal-title":"Chem Eng J"},{"key":"4497_CR172","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202402516","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Niu X, Ding C, Lin Y, Fang W, Yan L, Cheng J, Zou J, Tian Y, Huang W (2024a) Carrier-free self-assembly nano-sonosensitizers for sonodynamic-amplified cuproptosis-ferroptosis in glioblastoma therapy. Adv Sci. https:\/\/doi.org\/10.1002\/advs.202402516","journal-title":"Adv Sci"},{"key":"4497_CR173","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/s41419-024-07206-3","volume":"15","author":"Z Zhu","year":"2024","unstructured":"Zhu Z, Song M, Ren J, Liang L, Mao G, Chen M (2024b) Copper homeostasis and cuproptosis in central nervous system diseases. Cell Death Dis 15:850","journal-title":"Cell Death Dis"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04497-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04497-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04497-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T22:03:11Z","timestamp":1771538591000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04497-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":173,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["4497"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04497-x","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,12]]},"assertion":[{"value":"11 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Since this research used only publicly available data and no human participants, ethical review and approval were not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}